TERESA SMITH: Open Payments
NPI 1326411679 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 54 payments from 17 companies in 2025. Trend: 2023 $1,561 · 2024 $1,766 · 2025 $1,905
Food & beverage: $1,905
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $527 |
| Phathom Pharmaceuticals, Inc. | 3 | $189 |
| GlaxoSmithKline, LLC. | 17 | $161 |
| Novo Nordisk Inc | 3 | $160 |
| Astellas Pharma US Inc | 2 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $110 |
| Lilly USA, LLC | 5 | $86 |
Products named: BREZTRI, VOQUEZNA, AIRSUPRA, TRELEGY ELLIPTA, Veozah, Kerendia, REZDIFFRA, REXULTI.
Industry payments across TX — which companies pay providers there.
